Cargando…

Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis

Parasitic worms are able to survive in their mammalian host for many years due to their ability to manipulate the immune response by secreting immunomodulatory products. It is increasingly clear that, reflecting the anti-inflammatory actions of such worm-derived immunomodulators, there is an inverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pineda, M A, Al-Riyami, L, Harnett, W, Harnett, M M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Science Inc 2014
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089150/ https://www.ncbi.nlm.nih.gov/pubmed/24666108 http://dx.doi.org/10.1111/cei.12252

Ejemplares similares

ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints
por: Pineda, Miguel A., et al.
Publicado: (2014)

The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype
por: Rzepecka, Justyna, et al.
Publicado: (2013)

The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ
por: Eason, Russell J., et al.
Publicado: (2016)

Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties
por: Rzepecka, Justyna, et al.
Publicado: (2014)

Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation
por: Al-Riyami, Lamyaa, et al.
Publicado: (2015)

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints
por: Rodgers, David T, et al.
Publicado: (2014)

IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62
por: Ball, Dimity H., et al.
Publicado: (2018)

Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62
por: Ball, Dimity H., et al.
Publicado: (2013)

Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
por: Al-Riyami, Lamyaa, et al.
Publicado: (2013)

The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis
por: Doonan, James, et al.
Publicado: (2019)

The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
por: Rodgers, David T, et al.
Publicado: (2015)

Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts
por: Corbet, Marlene, et al.
Publicado: (2021)

Development of Acanthocheilonema viteae in Meriones shawi: Absence of microfilariae and production of active ES‐62
por: Lumb, Felicity E., et al.
Publicado: (2020)

The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
por: Coltherd, J. C., et al.
Publicado: (2016)

The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation
por: Ahmed, Umul Kulthum, et al.
Publicado: (2016)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015)

Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis
por: Doonan, James, et al.
Publicado: (2018)

A novel therapeutic approach to cytokine modulation in articular inflammation using filarial nematode derived ES-62
por: McInnes, IB, et al.
Publicado: (2003)

The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62
por: Bell, Kara S., et al.
Publicado: (2015)

Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62
por: Lumb, Felicity E., et al.
Publicado: (2017)

Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
por: Janicova, L., et al.
Publicado: (2016)

Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease
por: Doonan, James, et al.
Publicado: (2018)

Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling
por: Suckling, Colin J., et al.
Publicado: (2018)

The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing
por: Crowe, Jenny, et al.
Publicado: (2020)

The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing
por: Harnett, Margaret M., et al.
Publicado: (2022)

Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
por: North, Simon J, et al.
Publicado: (2019)

Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome
por: Rzepecka, Justyna, et al.
Publicado: (2015)

Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4(+) Th-Cells
por: Mouser, Emily E. I. M., et al.
Publicado: (2016)

Primary Nonadherence, Associated Clinical Outcomes, and Health Care Resource Use Among Patients with Rheumatoid Arthritis Prescribed Treatment with Injectable Biologic Disease-Modifying Antirheumatic Drugs
por: Harnett, James, et al.
Publicado: (2016)

Apicomplexan autophagy and modulation of autophagy in parasite-infected host cells
por: Latré de Laté, Perle, et al.
Publicado: (2017)

Highlights of Strategies Targeting Fibroblasts for Novel Therapies for Rheumatoid Arthritis
por: Chu, Cong-Qiu
Publicado: (2022)

Machine development SE 62 integer resonance with ES 43
por: Bleeker, J, et al.
Publicado: (1971)

Novel integrated computational AMP discovery approaches highlight diversity in the helminth AMP repertoire
por: Irvine, Allister, et al.
Publicado: (2023)

From Christian de Duve to Yoshinori Ohsumi: More to autophagy than just dining at home
por: Harnett, Margaret M., et al.
Publicado: (2017)

Cytohesin-2/ARNO: A Novel Bridge Between Cell Migration and Immunoregulation in Synovial Fibroblasts
por: Wang, Yilin, et al.
Publicado: (2022)

Correspondence
por: Harnett, J. M.
Publicado: (1868)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Rheumatoid arthritis: the old issue, the new therapeutic approach
por: Babaahmadi, Mahnaz, et al.
Publicado: (2023)

Learning Articulate Storyline
por: Harnett, Stephanie
Publicado: (2013)

On the Application of Artificial Teeth upon the Atmospheric Pressure, or Suction Principle
por: Harnett, William
Publicado: (1845)

Cannot write session to /tmp/vufind_sessions/sess_1vi2c8g2vsq2oouaki4o2ll5o5